Edition:
India

Neovasc Inc (NVCN.OQ)

NVCN.OQ on NASDAQ Stock Exchange Capital Market

0.63USD
11:02pm IST
Change (% chg)

$-0.03 (-4.21%)
Prev Close
$0.66
Open
$0.66
Day's High
$0.66
Day's Low
$0.63
Volume
25,989
Avg. Vol
82,066
52-wk High
$3.12
52-wk Low
$0.63

Latest Key Developments (Source: Significant Developments)

Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Neovasc Inc ::CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING.  Full Article

Neovasc announces 65 million dollars offering of common shares and warrants
Friday, 10 Nov 2017 

Nov 10 (Reuters) - NEOVASC INC ::NEOVASC ANNOUNCES US$65 MILLION UNDERWRITTEN OFFERING OF UNITS CONSISTING OF COMMON SHARES AND WARRANTS TO PURCHASE COMMON SHARES AND CONCURRENT PRIVATE PLACEMENT OF NOTES AND WARRANTS.‍PRICE OF US$1.46 PER UNIT FOR GROSS PROCEEDS OF APPROXIMATELY US$37.487 MILLION​.WILL ALSO COMPLETE BROKERED PRIVATE PLACEMENT FOR SALE OF US$32,750,000 AGGREGATE PRINCIPAL AMOUNT OF SENIOR SECURED CONVERTIBLE NOTES FOR GROSS PROCEEDS OF US$27,837,500​.‍ CANACCORD GENUITY INC. IS ACTING AS SOLE BOOK-RUNNING MANAGER FOR OFFERING​.‍CANACCORD GENUITY INC ACTS ALSO AS SOLE PLACEMENT AGENT FOR CONCURRENT PRIVATE PLACEMENT​.  Full Article

Neovasc receives FDA approval to initiate pivotal reducer trial
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Neovasc Inc :Neovasc receives FDA approval to initiate pivotal reducer trial.Neovasc Inc - ‍Co is currently evaluating start up timelines and funding options for Cosira-II trial​.  Full Article

Neovasc provides litigation update
Saturday, 4 Nov 2017 

Nov 3 (Reuters) - Neovasc Inc :Neovasc provides litigation update.Says Court Of Appeals affirmed judgment of U.S. District Court for District of Massachusetts in case of Cardiaq Valve Tech versus co.Says ‍full judgment of about US$112 million will now become due on November 13, 2017​.  Full Article

Neovasc and Boston Scientific closes $75 million agreement
Tuesday, 13 Dec 2016 

Neovasc Inc - : On Dec 12, U.S. District court for district of Massachusetts held hearing in connection with co's litigation against cardiaq . Court denied cardiaq's motion for temporary restraining order to prevent deal between neovasc and boston scientific corporation from closing . Court also indicated a willingness to stay enforcement of judgment against neovasc pending appeal .Stay enforcement subject to neovasc posting a partial bond in amount of US$70 million.  Full Article

Neovasc announces update in litigation with CardiAQ
Tuesday, 1 Nov 2016 

Neovasc Inc : Neovasc announces update in litigation with CardiAQ . Says in order, judge ruled in favor of cardiAQ on issue of inventorship of neovasc's '964 patent . Says at same time, judge denied CardiAQ's motion for an injunction that would have shut down development of tiara . Neovasc inc says the judge upheld jury's verdict and $70 million award against co, and awarded $21 million in enhanced damages to that award . Says believe this decision affirms Neovasc's rights to advance tiara program . Neovasc inc says upon entry of a judgment by trial court, co will immediately seek to stay payment of $70 million damages award .Says it will appeal validity of award, as well as ruling on inventorship.  Full Article

Neovasc Inc qtrly loss per share $1.25
Wednesday, 10 Aug 2016 

Neovasc Inc : Qtrly loss per share $1.25 . Circumstances relating to cardiaq litigation cast substantial doubt about company's ability to continue as a going concern .Revenues for three months ended june 30, 2016 were $1.7 million compared to revenues of $3 million.  Full Article

Neovasc Q2 revenue falls 42 pct to $1.711 mln
Wednesday, 10 Aug 2016 

Neovasc Inc : Neovasc reports second quarter results for 2016 .Q2 revenue fell 42 percent to $1.711 million.  Full Article

Neovasc says jury found in favor of CardiAQ on relief for contract breach
Friday, 20 May 2016 

Neovasc Inc : Jury found in favor of CardiAQ, on claims for relief for breach of contract, breach of duty of honesty in contractual performance . Says jury awarded $70 million on trade secret claim for relief, and no damages on contractual claims for relief . Jury issued advisory findings in favor of CardiAQ regarding its causes of action under Massachusetts Gen. Law. Ch. 93A & patent inventorship .Alexei Marko, Neovasc CEO said will be exploring our options regarding post-trial motions in trial court potentially, appellate process.  Full Article

Neovasc files for mixed shelf of up to $200 mln
Friday, 13 May 2016 

Neovasc Inc :Files for mixed shelf of up to $200 million - sec filing.  Full Article

BRIEF-Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc

* CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING Source text : [http://bit.ly/2kZxgLY] Further company coverage: